SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve(TM) Rat and Evolve(TM) Mouse
MWN-AI** Summary
SenesTech, Inc. is enhancing its direct-to-consumer strategy by taking over the management of its Evolve™ Rat and Evolve™ Mouse sales on Amazon, a move aimed at boosting revenue and profit margins. This transition, effective immediately, aligns with the company's commitment to e-commerce, which historically contributed over 50% of its revenue in 2025. Until now, a portion of those Amazon sales was managed by third parties, limiting control over product presentation and consumer engagement.
By internalizing Amazon operations, SenesTech anticipates improvements in sales optimization and marketing strategies. This hands-on approach enables the company to foster better customer interactions and streamline communication, ultimately retaining a greater share of e-commerce revenue. Interim Chief Operating Officer Michael Edell highlighted the benefits of direct management, expressing confidence in enhanced visibility into customer engagement and the alignment of messaging with operational efforts.
The Evolve products, recognized as non-lethal, EPA-designated minimal-risk rodent control solutions, address rodent overpopulation issues by targeting fertility, thereby serving as an effective alternative to traditional poisons. This strategic shift aims to further contemporary pest management methods, complementing the company's mission to create healthier environments.
As SenesTech expands its internal e-commerce resources, it is poised for immediate financial benefits with a broader impact expected in the second quarter. The company emphasizes its commitment to sustainable pest control solutions while advocating for cleaner, healthier communities. Looking forward, SenesTech remains optimistic about the growth opportunities inherent in this strategic evolution, reinforcing its dedication to innovation in pest management through fertility control.
MWN-AI** Analysis
SenesTech, Inc. (Nasdaq: SNES) has recently unveiled its strategy to directly manage sales of its Evolve™ Rat and Evolve™ Mouse products on Amazon, marking a significant pivot towards strengthening its direct-to-consumer channel. This decision is expected to bolster both revenue and margins in the e-commerce space, which already contributed over 50% of the company’s revenues in 2025.
By shifting from third-party management to internal handling of Amazon sales, SenesTech aims to enhance control over product presentation and customer communications. This transition will allow the company to leverage consumer insights and performance data more effectively, optimizing marketing strategies and potentially increasing sales conversions. Importantly, direct management is predicted to lead to higher revenue retention as the company will capture a greater share of sales that previously went to intermediaries.
Investors should take note of the potential for accelerated growth stemming from this strategy, especially as the company expects to see financial benefits materializing in the second quarter of 2026. The focus on direct sales is not only about improving immediate financial metrics but is also aligned with the broader objective of enhancing brand loyalty and customer engagement through improved purchasing experiences.
SenesTech’s products utilize non-lethal methods to address rodent infestations, aligning with the increasing consumer preference for sustainable pest management solutions. As public awareness of environmentally friendly products rises, the demand for Evolve could see substantial growth, further supported by direct marketing efforts.
Overall, the realignment of SenesTech's commercial strategy stands to position the company favorably within a burgeoning market. Investors would do well to monitor the impacts of this transition closely, as successful execution could lead to enhanced shareholder value and market prominence.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success
PHOENIX, Feb. 10, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES) today announced that it will begin directly managing sales of its Evolve™ Rat and Evolve™ Mouse products on Amazon. The change reflects the Company's continued focus on e-commerce as an important distribution channel and will be effective immediately.
In 2025, e-commerce represented over 50% of SenesTech's revenue, with about one half of that directly managed by the Company and the remainder managed by third parties (including Amazon sales). E-Commerce sales of Evolve have delivered steady revenue growth, with Amazon serving as a key platform for introducing Evolve products to consumers and supporting product education.
By bringing Amazon operations in-house, SenesTech expects to gain greater control over product presentation and consumer communications, while leveraging performance data to optimize sales and marketing efforts. Direct management will also allow the Company to sell directly to consumers, which is expected to result in the retention of a greater portion of e-commerce revenue. This transition supports SenesTech's broader efforts to enhance its direct-to-consumer capabilities and provide customers with multiple purchasing options.
In recent months, the Company has expanded its internal e-commerce resources, including leadership support and operational expertise, to support this transition.
"We believe that managing Amazon sales internally will give us greater visibility into customer engagement and allow us to more directly align our messaging, data, and operations," said Michael Edell, Interim Chief Operating Officer of SenesTech. "With a Q1 implementation, the financial benefits will start immediately but we expect them to be more impactful in Q2."
Evolve is a non-lethal, EPA-designated minimum-risk rodent control soft bait that targets the root cause of infestations—rodent overpopulation—by reducing fertility in both male and female rodents. With Evolve, consumers and pest professionals alike gain access to a sustainable, effective alternative to traditional poisons.
About SenesTech, Inc.
SenesTech is committed to creating healthier environments by managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
For more information, visit https://senestech.com.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. Such forward-looking statements include, among others, statements regarding our plans for directly managing sales of products on Amazon, and the benefits anticipated from the transition to direct management of those sales; our expectation for accelerated growth across e-commerce sites; and our mission to provide products that are proactive, safe and sustainable; and our belief that ContraPest and Evolve are intended to fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management.
You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the risk that our direct management of sales on Amazon may not result in the benefits anticipated; risks relating to the successful commercialization of our products and market acceptance of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
Company Contact:
Tom Chesterman, CFO
928-233-7533
SOURCE SenesTech, Inc.
FAQ**
How does SenesTech Inc. SNES plan to leverage performance data to optimize sales and marketing efforts after taking direct control of Amazon sales of its Evolve™ products?
What financial benefits does SenesTech Inc. SNES anticipate from managing its Amazon sales internally, and how are these expected to unfold in Q1 and Q2?
Given that e-commerce represented over 50% of revenue for SenesTech Inc. SNES in 2025, what strategies will the company implement to enhance its direct-to-consumer capabilities moving forward?
What risks does SenesTech Inc. SNES foresee in the transition to direct management of Amazon sales, and how does the company plan to mitigate these risks?
**MWN-AI FAQ is based on asking OpenAI questions about SenesTech Inc. (NASDAQ: SNES).
NASDAQ: SNES
SNES Trading
-4.31% G/L:
$2.0095 Last:
26,713 Volume:
$2.12 Open:
